Christopher Burns
-
After ‘Challenging but Rewarding Journey’, CEO of Malvern’s Venatorx Pharmaceuticals Steps Down
Christopher Burns, a co-founder of Malvern-based Venatorx Pharmaceuticals, is stepping down from his position as the company’s CEO, writes John George for the Philadelphia Business…
-
Next Wave of Antibiotics Being Developed in a Malvern Lab
Malvern-based VenatoRx Pharmaceuticals is working hard to develop the next wave of antibiotics to fight hard-to-treat bacterial and viral infections, writes Queen Muse for Philadelphia…
-
Malvern-Based Antibiotics Developer Awarded $4.1 Million for Research Targeting Drug-Resistant STD
A global nonprofit partnership has awarded Malvern-based VenatoRx Pharmaceuticals $4.1 million to develop a treatment for a drug-resistant STD, writes John George for the Philadelphia…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
